Insights - BioBoston Consulting: Expert Analysis in Biotech and Life Sciences

BioBoston Consulting

Insights

Strategic pharmaceutical technology transfer in response to tariffs

ICH Q9 for Better Technology Transfer

This article explores how risk-based strategies enable more reliable, efficient technology transfer under GMP—helping life sciences organizations maintain product quality while accelerating timelines.

Read More »